These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21830452)

  • 21. Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
    Centofanti M; Oddone F; Gandolfi S; Hommer A; Boehm A; Tanga L; Sangermani C; Sportelli V; Haustein M; Manni G; Rossetti L
    Am J Ophthalmol; 2010 Oct; 150(4):575-80. PubMed ID: 20688314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
    Brandt JD; Cantor LB; Katz LJ; Batoosingh AL; Chou C; Bossowska I;
    J Glaucoma; 2008; 17(3):211-6. PubMed ID: 18414107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy.
    Kashiwagi K
    Jpn J Ophthalmol; 2012 Jul; 56(4):339-45. PubMed ID: 22581454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy.
    Kovacić Z; Stanić R; Rogosić V; Bojić L; Ivanisević M; Capkun V
    Acta Clin Croat; 2009 Mar; 48(1):31-3. PubMed ID: 19623869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
    Holló G; Kóthy P
    Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
    Chiseliţă D; Antohi I; Medvichi R; Danielescu C
    Oftalmologia; 2005; 49(3):39-45. PubMed ID: 16408674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
    Ozturk F; Ermis SS; Inan UU
    Acta Ophthalmol Scand; 2007 Feb; 85(1):80-3. PubMed ID: 17244215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension.
    Robin AL
    Eur J Ophthalmol; 2007; 17(4):685-6; author reply 686-7. PubMed ID: 17671954
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.
    Konstas AG; Holló G; Mikropoulos D; Tsironi S; Haidich AB; Embeslidis T; Georgiadou I; Irkec M; Melamed S
    Br J Ophthalmol; 2010 Feb; 94(2):209-13. PubMed ID: 19825835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bimatoprost/timolol versus travoprost/timolol fixed combinations in an Egyptian population: a hospital-based prospective randomized study.
    Macky TA
    J Glaucoma; 2014; 23(8):561-6. PubMed ID: 23429621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
    Varma R; Hwang LJ; Grunden JW; Bean GW
    Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraocular pressure lowering efficacy and safety of travoprost 0.004% as a replacement therapy in patients with open angle glaucoma or ocular hypertension.
    Ge J; Sun XH; Wang NL; Zhao JL; Wu LL; Chen XM; Wang ZX; Li B
    Chin Med J (Engl); 2010 Jun; 123(11):1417-21. PubMed ID: 20819599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
    Baiza-Durán LM; Alvarez-Delgado J; Contreras-Rubio AY; Medrano-Palafox J; De Luca-Brown A; Casab-Rueda H; Cortés-Gastélum MA; Garcidueñas-Mejía MJ; Gómez-Bastar P; Gil-Carrasco F; Hartleben-Matkin C; Jiménez-Román J; Moreno-Marín ML; Paczka-Zapata JA; Velasco-Gallegos G; Vergara-Sinta M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):174-8. PubMed ID: 20214051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative efficacy of prostaglandins.
    Laxmana Rao HB; Sekhar GC
    Ophthalmology; 2009 Jul; 116(7):1418; author reply 1418-9. PubMed ID: 19576507
    [No Abstract]   [Full Text] [Related]  

  • 38. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
    Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C
    Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corneal thickness and glaucoma medications.
    Mehdizadeh M; Jamshidian-Tehrani M; Nowroozzadeh MH
    Ophthalmology; 2009 Jul; 116(7):1416-7; author reply 1417, 1417.e1. PubMed ID: 19576505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.